Multimodal Ultrasound in Peripheral Neuropathy

This study will enforce the role of ultrasound in early diagnosis and screening on peripheral neuropathy in comparison with other modalities.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Peripheral Neuropathy Nervous System Diseases Neuromuscular Diseases Peripheral Nervous System Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

About this study

Each case will undergo informed Written consent and will be told the aim of the study including benefits, no harm from this procedure to the participants.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with clinical symptoms of peripheral neuropathy

Exclusion criteria

patients with unhealthy tissue texture to put on probe

Treatment and study plan

Primary outcomes

The Role of multimodal ultrasonography in evaluation of peripheral neuropathy

Time frame: 3 years

Enforce the role of ultrasound in screening and early detection of nerve affection in peripheral neuropathy in comparison with the traditional modalities as nerve biopsy and nerve conduction

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Role of Multimodal Ultrasonography in Evaluation of Peripheral Neuropathy

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2026
First posted: Dec 2, 2024
Registry last updated: Feb 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not yet recruiting